Document Detail


The effect of angiotensin receptor blockers for preventing atrial fibrillation.
MedLine Citation:
PMID:  17686377     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Atrial fibrillation is the most common sustained cardiac arrhythmia in clinical practice, and causes significant burden to patients and health care systems. Clinicians treat existing atrial fibrillation with anticoagulation and/or drugs that utilize either a rate or rhythm control strategy. It remains unclear how best to reduce cardiovascular morbidity and mortality in this population. Prevention of atrial fibrillation using angiotensin receptor blockers, which affect ion currents and refractoriness in atrial myocytes, regress or prevent atrial fibrosis, decrease left atrial size, regress left ventricular hypertrophy, modulate sympathetic nerve activity, reduce inflammation, and reduce blood pressure, may become an important and desirable alternative.
Authors:
Kristian Wachtell; Richard B Devereux; And Paulette A Lyle
Related Documents :
1378157 - Effects of carvedilol on atrial natriuretic peptide, catecholamines, and hemodynamics i...
17541727 - An integrated approach to determine left atrial volume, mass and function in hypertroph...
1838027 - Atrial natriuretic peptides in essential hypertension: basal plasma levels and relation...
11077137 - Lung water, hemodynamics and dyspnea before and after valvuloplasty in mitral stenosis.
23140827 - Effects of extracellular pressure and alcohol on the microglial response to inflammator...
11029347 - Accuracy of hemodynamic measurements during partial liquid ventilation with perflubron.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Current hypertension reports     Volume:  9     ISSN:  1522-6417     ISO Abbreviation:  Curr. Hypertens. Rep.     Publication Date:  2007 Aug 
Date Detail:
Created Date:  2007-08-09     Completed Date:  2008-03-21     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100888982     Medline TA:  Curr Hypertens Rep     Country:  United States    
Other Details:
Languages:  eng     Pagination:  278-83     Citation Subset:  IM    
Affiliation:
Department of Cardiology B2142, Rigshospitalet, The Heart Center, 9 Blegdamsvej, DK-2100 Copenhagen, Denmark. kristian@wachtell.net
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angiotensin II Type 1 Receptor Blockers / pharmacology*,  therapeutic use*
Atrial Fibrillation / epidemiology,  prevention & control*
Humans
Primary Prevention / methods*
Recurrence
Risk Factors
Chemical
Reg. No./Substance:
0/Angiotensin II Type 1 Receptor Blockers

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The vasodilatory beta-blockers.
Next Document:  Combination therapy with renin-angiotensin system blockers: will amlodipine replace hydrochlorothiaz...